S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
NYSE:IVC

Invacare - IVC Stock Forecast, Price & News

$0.80
+0.02 (+2.56%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.78
$0.82
50-Day Range
$0.78
$1.15
52-Week Range
$0.76
$5.36
Volume
148,539 shs
Average Volume
635,622 shs
Market Capitalization
$28.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Invacare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,025.0% Upside
$9.00 Price Target
Short Interest
Bearish
21.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.43mentions of Invacare in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.92) to ($0.94) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Medical Sector

578th out of 1,072 stocks

Surgical Appliances & Supplies Industry

14th out of 25 stocks

IVC stock logo

About Invacare (NYSE:IVC) Stock

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Stock News Headlines

See More Headlines
Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Company Calendar

Last Earnings
8/08/2022
Today
10/06/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
46120310
Employees
3,000
Year Founded
1885

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+1,025.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-45,560,000.00
Pretax Margin
-7.29%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Cash Flow
$0.84 per share
Book Value
$5.54 per share

Miscellaneous

Free Float
33,188,000
Market Cap
$28.52 million
Optionable
Optionable
Beta
0.51

Social Links


Key Executives

  • Ms. Kathleen P. Leneghan (Age 59)
    Sr. VP & CFO
    Comp: $485.86k
  • Mr. Anthony C. LaPlacaMr. Anthony C. LaPlaca (Age 64)
    Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec.
    Comp: $467.65k
  • Mr. Joost Beltman (Age 53)
    Sr. VP & GM of North America
    Comp: $446.31k
  • Ms. Angela Goodwin (Age 58)
    Sr. VP & Chief Information Technology Officer
    Comp: $328.96k
  • Mr. Geoffrey P. Purtill (Age 52)
    Interim CEO & Pres
  • Lois Lee CTP
    Director of Treasury, Investor Relations & Corp. Comm.
  • Mr. Rick A. Cassiday (Age 56)
    Sr. VP & Chief HR Officer













IVC Stock - Frequently Asked Questions

Should I buy or sell Invacare stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IVC shares.
View IVC analyst ratings
or view top-rated stocks.

What is Invacare's stock price forecast for 2022?

1 analysts have issued 1 year target prices for Invacare's shares. Their IVC share price forecasts range from $9.00 to $9.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 1,025.0% from the stock's current price.
View analysts price targets for IVC
or view top-rated stocks among Wall Street analysts.

How have IVC shares performed in 2022?

Invacare's stock was trading at $2.72 on January 1st, 2022. Since then, IVC shares have decreased by 70.6% and is now trading at $0.80.
View the best growth stocks for 2022 here
.

When is Invacare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our IVC earnings forecast
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its quarterly earnings results on Monday, August, 8th. The health services provider reported ($0.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by $0.09. The health services provider had revenue of $189.02 million for the quarter, compared to analyst estimates of $212.59 million. Invacare had a negative net margin of 7.97% and a negative trailing twelve-month return on equity of 22.20%. During the same quarter in the previous year, the firm posted ($0.28) EPS.

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

How do I buy shares of Invacare?

Shares of IVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $0.80.

How much money does Invacare make?

Invacare (NYSE:IVC) has a market capitalization of $28.52 million and generates $872.46 million in revenue each year. The health services provider earns $-45,560,000.00 in net income (profit) each year or ($1.91) on an earnings per share basis.

How many employees does Invacare have?

The company employs 3,000 workers across the globe.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The official website for the company is www.invacare.com. The health services provider can be reached via phone at (440) 329-6000, via email at loislee@invacare.com, or via fax at 877-619-7996.

This page (NYSE:IVC) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.